This contrasts with the currently understood action of LSAMP in other human adenocarcinoma models and the proposed suppressor role of LSAMP among other human malignancies, where LSAMP expression downregulates the RTK pathway and suppresses tumor growth. The gene discussed is LSAMP; the disease is neoplasm.